The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes (original) (raw)

• Campioni, S. et al. A causative link between the structure of aberrant protein oligomers and their toxicity. Nat. Chem. Biol. 6, 140–147 (2010).
  Article CAS PubMed Google Scholar
• Hardy, J. & Selkoe, D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353–356 (2002).
  Article CAS PubMed Google Scholar
• Karran, E., Mercken, M. & De Strooper, B. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat. Rev. Drug Discov. 10, 698–712 (2011).
  Article CAS PubMed Google Scholar
• De Strooper, B. Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Physiol. Rev. 90, 465–494 (2010).
  Article CAS PubMed Google Scholar
• Castellano, J.M. et al. Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci. Transl. Med. 3, 89ra57 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Cerf, E., Gustot, A., Goormaghtigh, E., Ruysschaert, J.M. & Raussens, V. High ability of apolipoprotein E4 to stabilize amyloid-beta peptide oligomers, the pathological entities responsible for Alzheimer's disease. FASEB J. 25, 1585–1595 (2011).
  Article CAS PubMed Google Scholar
• Shen, J. & Kelleher, R.J. III. The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc. Natl. Acad. Sci. USA 104, 403–409 (2007).
  Article CAS PubMed Google Scholar
• Perrin, R.J., Fagan, A.M. & Holtzman, D.M. Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 461, 916–922 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Pike, C.J., Walencewicz, A.J., Glabe, C.G. & Cotman, C.W. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311–314 (1991).
  Article CAS PubMed Google Scholar
• Harper, J.D., Wong, S.S., Lieber, C.M. & Lansbury, P.T. Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem. Biol. 4, 119–125 (1997).
  Article CAS PubMed Google Scholar
• Walsh, D.M., Lomakin, A., Benedek, G.B., Condron, M.M. & Teplow, D.B. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J. Biol. Chem. 272, 22364–22372 (1997).
  Article CAS PubMed Google Scholar
• Oda, T. et al. Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress. Exp. Neurol. 136, 22–31 (1995).
  Article CAS PubMed Google Scholar
• Lambert, M.P. et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95, 6448–6453 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Walsh, D.M. et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535–539 (2002).
  Article CAS PubMed Google Scholar
• McLean, C.A. et al. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46, 860–866 (1999).
  Article CAS PubMed Google Scholar
• Mc Donald, J.M. et al. The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. Brain 133, 1328–1341 (2010).
  Article PubMed PubMed Central Google Scholar
• Nilsberth, C. et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat. Neurosci. 4, 887–893 (2001).
  Article CAS PubMed Google Scholar
• Tomiyama, T. et al. A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia. Ann. Neurol. 63, 377–387 (2008).
  Article CAS PubMed Google Scholar
• Kumar, S. et al. Extracellular phosphorylation of the amyloid beta-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease. EMBO J. 30, 2255–2265 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Jarrett, J.T., Berger, E.P. & Lansbury, P.T. Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693–4697 (1993).
  Article CAS PubMed Google Scholar
• Portelius, E. et al. Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease. Mol. Neurodegener. 5, 2 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Lee, J., Culyba, E.K., Powers, E.T. & Kelly, J.W. Amyloid-beta forms fibrils by nucleated conformational conversion of oligomers. Nat. Chem. Biol. 7, 602–609 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Bezprozvanny, I. Amyloid goes global. Sci. Signal. 2, pe16 (2009).
  Article PubMed PubMed Central Google Scholar
• Bitan, G., Fradinger, E.A., Spring, S.M. & Teplow, D.B. Neurotoxic protein oligomers–what you see is not always what you get. Amyloid 12, 88–95 (2005).
  Article PubMed Google Scholar
• Hepler, R.W. et al. Solution state characterization of amyloid beta-derived diffusible ligands. Biochemistry 45, 15157–15167 (2006).
  Article CAS PubMed Google Scholar
• Wogulis, M. et al. Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death. J. Neurosci. 25, 1071–1080 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Kuperstein, I. et al. Neurotoxicity of Alzheimer's disease Abeta peptides is induced by small changes in the Abeta42 to Abeta40 ratio. EMBO J. 29, 3408–3420 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Cleary, J.P. et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci. 8, 79–84 (2005).
  Article CAS PubMed Google Scholar
• Ittner, L.M. et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142, 387–397 (2010).
  Article CAS PubMed Google Scholar
• Li, S. et al. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62, 788–801 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, H.Y. et al. Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J. Neurosci. 30, 2636–2649 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Jo, J. et al. Abeta(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3beta. Nat. Neurosci. 14, 545–547 (2011).
  Article CAS PubMed Google Scholar
• Hardy, J. The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J. Neurochem. 110, 1129–1134 (2009).
  Article CAS PubMed Google Scholar
• Shankar, G.M. et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14, 837–842 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• O'Nuallain, B. et al. Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils. J. Neurosci. 30, 14411–14419 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Noguchi, A. et al. Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains. J. Biol. Chem. 284, 32895–32905 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Matsumura, S. et al. Two distinct amyloid β-protein (Aβ) assembly pathways leading to oligomers and fibrils identified by combined fluorescence correlation spectroscopy, morphology and toxicity analyses. J. Biol. Chem. (2011).
• Shankar, G.M. et al. Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Abeta assembly forms throughout life. Neurobiol. Dis. 36, 293–302 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Lesné, S. et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352–357 (2006).
  Article CAS PubMed Google Scholar
• Hartley, D.M. et al. Transglutaminase induces protofibril-like amyloid beta-protein assemblies that are protease-resistant and inhibit long-term potentiation. J. Biol. Chem. 283, 16790–16800 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Smith, D.P. et al. Copper-mediated amyloid-beta toxicity is associated with an intermolecular histidine bridge. J. Biol. Chem. 281, 15145–15154 (2006).
  Article CAS PubMed Google Scholar
• Galeazzi, L., Ronchi, P., Franceschi, C. & Giunta, S. In vitro peroxidase oxidation induces stable dimers of beta-amyloid (1-42) through dityrosine bridge formation. Amyloid 6, 7–13 (1999).
  Article CAS PubMed Google Scholar
• Baumketner, A. et al. Amyloid beta-protein monomer structure: a computational and experimental study. Protein Sci. 15, 420–428 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Kayed, R. et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2, 18 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Caughey, B. & Lansbury, P.T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26, 267–298 (2003).
  Article CAS PubMed Google Scholar
• Hu, X. et al. Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc. Natl. Acad. Sci. USA 106, 20324–20329 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Townsend, M., Shankar, G.M., Mehta, T., Walsh, D.M. & Selkoe, D.J. Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J. Physiol. (Lond.) 572, 477–492 (2006).
  Article CAS Google Scholar
• Reed, M.N. et al. Cognitive effects of cell-derived and synthetically derived Abeta oligomers. Neurobiol. Aging 32, 1784–1794 (2011).
  Article CAS PubMed Google Scholar
• Jin, M. et al. Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc. Natl. Acad. Sci. USA 108, 5819–5824 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Yamin, G. NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus. J. Neurosci. Res. 87, 1729–1736 (2009).
  Article CAS PubMed Google Scholar
• Dineley, K.T. et al. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. J. Neurosci. 21, 4125–4133 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Giuffrida, M.L. et al. The monomer state of beta-amyloid: where the Alzheimer's disease protein meets physiology. Rev. Neurosci. 21, 83–93 (2010).
  Article CAS PubMed Google Scholar
• Soucek, T., Cumming, R., Dargusch, R., Maher, P. & Schubert, D. The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39, 43–56 (2003).
  Article CAS PubMed Google Scholar
• Thathiah, A. & De Strooper, B. G protein-coupled receptors, cholinergic dysfunction, and Abeta toxicity in Alzheimer's disease. Sci. Signal. 2, re8 (2009).
  Article PubMed Google Scholar
• Laurén, J., Gimbel, D.A., Nygaard, H.B., Gilbert, J.W. & Strittmatter, S.M. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457, 1128–1132 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Ross, C.A. & Poirier, M.A. Opinion: What is the role of protein aggregation in neurodegeneration? Nat. Rev. Mol. Cell Biol. 6, 891–898 (2005).
  Article CAS PubMed Google Scholar
• Collinge, J. & Clarke, A.R. A general model of prion strains and their pathogenicity. Science 318, 930–936 (2007).
  Article CAS PubMed Google Scholar
• Meyer-Luehmann, M. et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313, 1781–1784 (2006).
  Article CAS PubMed Google Scholar
• Eisele, Y.S. et al. Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 330, 980–982 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Morales, R., Duran-Aniotz, C., Castilla, J., Estrada, L.D. & Soto, C. De novo induction of amyloid-beta deposition in vivo. Mol. Psychiatry (2011).
• Baker, H.F., Ridley, R.M., Duchen, L.W., Crow, T.J. & Bruton, C.J. Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol. Neurobiol. 8, 25–39 (1994).
  Article CAS PubMed Google Scholar
• Aguzzi, A. & Calella, A.M. Prions: protein aggregation and infectious diseases. Physiol. Rev. 89, 1105–1152 (2009).
  Article CAS PubMed Google Scholar
• Petkova, A.T. et al. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 307, 262–265 (2005).
  Article CAS PubMed Google Scholar
• Anonymous. State of aggregation. Nat. Neurosci. 14, 399 (2011).
• Ono, K., Condron, M.M. & Teplow, D.B. Structure–neurotoxicity relationships of amyloid β-protein oligomers. Proc. Natl. Acad. Sci. USA 106, 14745–14750 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, C. et al. Characteristics of amyloid-related oligomers revealed by crystal structures of macrocyclic beta-sheet mimics. J. Am. Chem. Soc. 133, 6736–6744 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Schlenzig, D. et al. Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides. Biochemistry 48, 7072–7078 (2009).
  Article CAS PubMed Google Scholar
• Bleiholder, C., Dupuis, N.F., Wyttenbach, T. & Bowers, M.T. Ion mobility-mass spectrometry reveals a conformational conversion from random assembly to beta-sheet in amyloid fibril formation. Nat. Chem. 3, 172–177 (2011).
  Article CAS PubMed Google Scholar
• Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486–489 (2003).
  Article CAS PubMed Google Scholar
• Shughrue, P.J. et al. Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons. Neurobiol. Aging 31, 189–202 (2010).
  Article CAS PubMed Google Scholar
• O'Nuallain, B. et al. A monoclonal antibody against synthetic Abeta dimer assemblies neutralizes brain-derived synaptic plasticity-disrupting Abeta. J. Neurochem. 119, 189–201 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Lambert, M.P. et al. Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies. J. Neurochem. 79, 595–605 (2001).
  Article CAS PubMed Google Scholar
• Lambert, M.P. et al. Monoclonal antibodies that target pathological assemblies of Abeta. J. Neurochem. 100, 23–35 (2007).
  Article CAS PubMed Google Scholar
• Lee, E.B. et al. Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice. J. Biol. Chem. 281, 4292–4299 (2006).
  Article CAS PubMed Google Scholar
• Moretto, N. et al. Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide. J. Biol. Chem. 282, 11436–11445 (2007).
  Article CAS PubMed Google Scholar
• Schupf, N. et al. Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 105, 14052–14057 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Gardberg, A.S. et al. Molecular basis for passive immunotherapy of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 104, 15659–15664 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Englund, H. et al. Sensitive ELISA detection of amyloid-beta protofibrils in biological samples. J. Neurochem. 103, 334–345 (2007).
  CAS PubMed Google Scholar
• Lord, A. et al. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease. Neurobiol. Dis. 36, 425–434 (2009).
  Article CAS PubMed Google Scholar
• Hillen, H. et al. Generation and therapeutic efficacy of highly oligomer-specific beta-amyloid antibodies. J. Neurosci. 30, 10369–10379 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• O'Nuallain, B. & Wetzel, R. Conformational Abs recognizing a generic amyloid fibril epitope. Proc. Natl. Acad. Sci. USA 99, 1485–1490 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Barghorn, S. et al. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J. Neurochem. 95, 834–847 (2005).
  Article CAS PubMed Google Scholar
• van Helmond, Z., Heesom, K. & Love, S. Characterisation of two antibodies to oligomeric Abeta and their use in ELISAs on human brain tissue homogenates. J. Neurosci. Methods 176, 206–212 (2009).
  Article CAS PubMed Google Scholar
• Habicht, G. et al. Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils. Proc. Natl. Acad. Sci. USA 104, 19232–19237 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Lafaye, P., Achour, I., England, P., Duyckaerts, C. & Rougeon, F. Single-domain antibodies recognize selectively small oligomeric forms of amyloid beta, prevent Abeta-induced neurotoxicity and inhibit fibril formation. Mol. Immunol. 46, 695–704 (2009).
  Article CAS PubMed Google Scholar
• Meli, G., Visintin, M., Cannistraci, I. & Cattaneo, A. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers. J. Mol. Biol. 387, 584–606 (2009).
  Article CAS PubMed Google Scholar
• Zameer, A., Kasturirangan, S., Emadi, S., Nimmagadda, S.V. & Sierks, M.R. Anti-oligomeric Abeta single-chain variable domain antibody blocks Abeta-induced toxicity against human neuroblastoma cells. J. Mol. Biol. 384, 917–928 (2008).
  Article CAS PubMed Google Scholar
• Sandberg, A. et al. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering. Proc. Natl. Acad. Sci. USA 107, 15595–15600 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Villemagne, V.L. et al. Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease. J. Neurosci. 30, 6315–6322 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Zempel, H., Thies, E., Mandelkow, E. & Mandelkow, E.M. Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J. Neurosci. 30, 11938–11950 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Shipton, O.A. et al. Tau protein is required for amyloid β-induced impairment of hippocampal long-term potentiation. J. Neurosci. 31, 1688–1692 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• De Felice, F.G. et al. Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers. Neurobiol. Aging 29, 1334–1347 (2008).
  Article CAS PubMed Google Scholar
• Wang, X., Perry, G., Smith, M.A. & Zhu, X. Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons. Neurodegener. Dis. 7, 56–59 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Demuro, A. et al. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280, 17294–17300 (2005).
  Article CAS PubMed Google Scholar
• Deshpande, A., Mina, E., Glabe, C. & Busciglio, J. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J. Neurosci. 26, 6011–6018 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Lasagna-Reeves, C.A., Glabe, C.G. & Kayed, R. Amyloid-β annular protofibrils evade fibrillar fate in Alzheimer's disease brain. J Biol Chem (2011).
• Xia, W. et al. Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J. Biol. Chem. 272, 7977–7982 (1997).
  Article CAS PubMed Google Scholar
• Podlisny, M.B. et al. Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J. Biol. Chem. 270, 9564–9570 (1995).
  Article CAS PubMed Google Scholar
• Roher, A.E. et al. Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem. 271, 20631–20635 (1996).
  Article CAS PubMed Google Scholar
• Hoshi, M. et al. Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta. Proc. Natl. Acad. Sci. USA 100, 6370–6375 (2003).
  Article CAS PubMed PubMed Central Google Scholar